Partners
From Access to Closure
Terumo's Interventional Systems division is a global leader in cardiovascular care, providing low invasive devices for the treatment of coronary artery disease. Terumo's philosophy is to deliver high quality devices with unique and innovative technology.
From Access to Closure
Terumo's Interventional Systems division is a global leader in cardiovascular care, providing low invasive devices for the treatment of coronary artery disease. Terumo's philosophy is to deliver high quality devices with unique and innovative technology. Terumo offers a comprehensive device portfolio including products for the diagnosis and treatment of coronary artery disease:
- Access & Diagnostic
- PCI Products
- Imaging Products
- Peripheral Stents
- PTA Balloons
- Support Catheters
- Aspiration
Terumo Cardiovascular
Terumo Cardiovascular provides medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass, intra-operative monitoring and cardiac surgery. This includes a full-line of perfusion products, electromechanical products, endoscopic vessel harvesting products and surgical stabilization products.
Our mission is to work as a team to save one more life, today and every day. We do this by providing lifesaving technology to cardiac surgery teams around the world.
Terumo Interventional Oncology
Terumo develops products for interventional radiologists that specialize in treating patients with oncological indications. Rising to the challenge of creating innovative treatments for patients, we bring you a complete range of interventional oncology products that focus on Access, Loco-regional treatments and Endovascular embolization.
BD - Helping all people live healthy lives
Global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care and treatment.
BD - Helping all people live healthy lives
Global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care and treatment.
The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.
BD offers a full range of clinically relevant product choices for interventional procedures. Our products and services for interventional procedures are designed to meet individual patient needs and help physicians deliver positive clinical outcomes using minimally invasive and percutaneous techniques.
Shockwave
Shockwave is a game changer in the IVL (Intravascular lithotripsy) treatment. The sonic pressure waves create a localized field effect within the vessel, to fracture the layers of calcium.
Shockwave
Shockwave is a game changer in the IVL (Intravascular lithotripsy) treatment. The sonic pressure waves create a localized field effect within the vessel, to fracture the layers of calcium.
This innovative technology plays two unique roles: to appose the vessel wall, and facilitate efficient energy transfer, and then to dilate the lesion to maximize lumen gain.
Shockwave can treat calcified arteries in heart and body.
Cytosorbents
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world...
Cytosorbents
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses.
These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® has been used in more than 131,000 human treatments to date. CytoSorb has received FDA Emergency Use Authorization in the United States for use in critically-ill COVID-19 patients with imminent or confirmed respiratory failure, in defined circumstances.
CytoSorb has also been granted FDA Breakthrough Designation for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery.
Pulsecath
Pulsecath medical device company that develops, manufactures and markets circulatory support systems. The company, has developed unique and proprietary platform technology to provide a short-term circulatory support system for cardiologists and cardiac surgeons.
Pulsecath
Pulsecath medical device company that develops, manufactures and markets circulatory support systems. The company, has developed unique and proprietary platform technology to provide a short-term circulatory support system for cardiologists and cardiac surgeons. The company's goal is to deliver novel solutions that reduce health care costs and improve patient outcomes.
Pulsecath Provide effective circulatory support systems to the cardiologist and cardiac surgeon that address a wide range of patients less-invasively and decrease the response time of patients.
Both cardiologists and cardiac surgeons are searching for better treatment solutions as a bridge to decision and to reduce the high incidence of morbidity and mortality for profound heart failure patients through:
- Earlier institution of circulatory support
- Ventricular unloading in combination with end-organ reperfusion
- Minimally invasive approaches
Adler ortho
Adler Ortho® can count on production units featuring state of the art and innovative design and production technologies. The entire production process is performed by the latest generation of numerical control machinery and 3D printers.
Adler ortho
Adler Ortho® can count on production units featuring state of the art and innovative design and production technologies.
The entire production process is performed by the latest generation of numerical control machinery and 3D printers. The technologies are thoroughly integrated with the R&D department, which is in charge of designing all the products.
This system allows us to minimise any possibility of human error and guarantees a high level of flexibility in the production. We can also promptly respond to the demands of the market, as well as achieve exceptional quality levels.
The uniqueness of Adler Ortho®‘s range of products is due to a series of extremely advanced and exclusive technologies
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Smart Healing™ solutions represent a new standard in patient care. Evolving at the intersection of technology and human biology, our technologies reduce antibiotic treatments and enable a better quality of life for patients.
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Smart Healing™ solutions represent a new standard in patient care.
Evolving at the intersection of technology and human biology, our technologies reduce antibiotic treatments and enable a better quality of life for patients.
At the core of our technology is S53P4 bioactive glass – a smart biomaterial consisting solely of elements that exist naturally in the human body. Characterized by its ability to firmly attach to living tissue and chemically bond with surrounding bone, S53P4 bioactive glass naturally facilitates the formation of new bone.
Thus, it is a unique material for filling defects and replacing damaged bone tissue because S53P4 bioactive glass functions as naturally as your biology.
Smart Healing™ solutions are osteostimulative, and come with a range of benefits for filling, reconstructing and regenerating bone defects as well as for filling bone cavities, voids and gaps in both adult and pediatric patients.
It’s time to heal smarter.
Dassiet, Woodcast
The story of Woodcast started at the Chemistry Department of the University of Helsinki, where Petro Lahtinen and Antti Pärssinen were working as researchers. Dr Lahtinen had just completed his Ph.D. on the application of oxidation catalytes to cellulose production; Dr Pärssinen on polymerisation catalytes.
Dassiet, Woodcast
The story of Woodcast started at the Chemistry Department of the University of Helsinki, where Petro Lahtinen and Antti Pärssinen were working as researchers. Dr Lahtinen had just completed his Ph.D. on the application of oxidation catalytes to cellulose production; Dr Pärssinen on polymerisation catalytes.
The pair began to reflect on their research over the last five, six years. Could there be a commercially viable innovation within the work that had already been completed? Antti had some biodegradable plastics left over from his research; Petro some wood chips, left over from the cellulose bleaching project. They started to mix the ingredients together and to manufacture various combinations of them.
After a year of purposeful experimentation, they had produced enough samples, and the researchers started to consider where their new wood composite material could be used.The first ideas for application were intuitive.
Petro and Antti had a notion that biodegradable plastics could be used in surgery, so they arranged for an appointment with a senior orthopaedic surgeon at the Töölö Hospital. This experienced professional could immediately see the potential in this revolutionary innovation and agreed to participate as an industry expert in the further development of the product.
ExsoMed
ExsoMed is dedicated to delivering innovative, high-quality technologies and products that will advance the standard of care and revolutionize hand surgery for our patients and surgeons throughout the world. For too long, few good options have led to sub-optimal results that have become the accepted norm.
ExsoMed
ExsoMed is dedicated to delivering innovative, high-quality technologies and products that will advance the standard of care and revolutionize hand surgery for our patients and surgeons throughout the world. For too long, few good options have led to sub-optimal results that have become the accepted norm.
Dissatisfied with the current standard of care in the orthopaedic hand space, veteran hand surgeons Dr. Lloyd Champagne and Dr. Jozef Zoldos set out to transform the way hand surgery is performed today.That pursuit became ExsoMed, a company focused on developing innovative techniques and products purposefully designed to revolutionize hand surgery.
Every day, we strive to help our surgeons achieve exceptional outcomes and happier patients. And this commitment has led us to invest heavily in product development, training, and education to advance the standard of care for our patients and surgeons everywhere.
Kinamed
Established in 1987, Kinamed designs and manufactures implantables and instruments for the orthopedics, cardiothoracic and neurosurgery specialties.
From Access to Closure
Established in 1987, Kinamed designs and manufactures implantables and instruments for the orthopedics, cardiothoracic and neurosurgery specialties. We manufacture and sell the following devices:
- CarboJet® CO2 Bone Preparation system – a revolutionary device for cleaning and preparing bone surfaces for orthopedic procedures;
- SuperCable® Iso-Elastic™ Cerclage system – a revolutionary polymer-based cerclage system designed to solve many of the inherent problems of traditional monofilament wire and cabling systems.
- KineMatch® Patello-Femoral Replacement – a unicompartmental joint replacement designed specifically for the small but challenging group of patients with isolated, end-stage patello-femoral disease.
- MD3T® Multi-Directional Tibial Tubercle Transfer – A system for reliable, reproducible tibial tubercle transfer.
Terumo Cardiovascular
Kinamed is certified by the British Standards Institute (BSI) to be in compliance with the requirements of ISO 13485. Our certificate number is FM 75124.
Kinamed is registered and licensed by the United States FDA, and the California Department of
MatOrtho
Company established by Mike Tuke in 2010 to continue the pioneering work of almost four decades conducted by his previous company, Finsbury Orthopaedics Limited, one of the most innovative British medical device manufacturers to date.
MatOrtho
Company established by Mike Tuke in 2010 to continue the pioneering work of almost four decades conducted by his previous company, Finsbury Orthopaedics Limited, one of the most innovative British medical device manufacturers to date.
Mike’s vision for MatOrtho® is to grow the business based on the design principles established by Finsbury and to be acknowledged as a pioneering trendsetter in the field of orthopaedic implant devices.
MatOrtho® is focused on improving the quality of life of all patients who receive one of its devices. The passion, knowledge and innovation which drove Finsbury lives on and is applied in a dynamic and ethical way.
Based in Leatherhead, MatOrtho® continues to employ many original Finsbury staff as well as the equipment manufacturing the supply of internationally-recognised orthopaedic implant devices such as the Medial Rotation Knee™ and the BOX® Total Ankle Replacement.
Our heritage is a true reflection of our commitment and responsibility as suppliers to medical professionals and, through continued investment in new technologies and product development, we aim to further demonstrate that commitment.
New Clip Technics
Founded in 2002, NEWCLIP TECHNICS is based near Nantes, in Western France. The company designs, manufactures and markets various ranges of osteosynthesis implants for elective surgery or traumatology.
New Clip Technics
Founded in 2002, NEWCLIP TECHNICS is based near Nantes, in Western France. The company designs, manufactures and markets various ranges of osteosynthesis implants for elective surgery or traumatology.
Innovation, quality and performance are at the heart of our company's values.
Innovation: We are committed to developing innovative products through an ambitious R&D program, as confirmed by numerous international patents such as the prize-winning (French Ministry of Research) polyaxial locking mechanism Dual Tech System (DTS®).
Quality: We care deeply about constantly improving our products to maintain the highest standards of quality and we offer products well-adapted to the market, in keeping with current international standards. NEWCLIP TECHNICS has been granted ISO 13485: 2003 Certification.
Performance: With our top-of-the-range machinery and equipment, we continue to invest in the latest cutting-edge technologies to design and turn out innovative high-performance products.
Our customers' satisfaction is a priority and thanks to our latest design tools and production means, we are gradually extending our range of products.
Novagenit
DAC® is a Class III, EC marked medical device.
DAC® is composed of two bioresorbable polymers: Hyaluronic acid and Poly-lactic acid
Novagenit
DAC® is a Class III, EC marked medical device.
DAC® is composed of two bioresorbable polymers: Hyaluronic acid and Poly-lactic acid It is produced in the form of a powder that, to obtain the hydrogel formulation, must be hydrated with water for preparations that are injectable alone, or in solution with an antibiotic. The indication is the prevention of peri-implant infection.
Said prevention is obtained by coating the implant components or internal fixation devices with DAC® hydrogel before implant insertion in the operating theatre in order to create a protective barrier against bacterial adherence.
Globus Medical
Globus Medical is a leading medical device manufacturer with the goal of improving the quality of life for patients with musculoskeletal disorders. We are inspired by the needs of these patients and by the surgeons and healthcare providers who treat them.
Globus Medical
Globus Medical is a leading medical device manufacturer with the goal of improving the quality of life for patients with musculoskeletal disorders. We are inspired by the needs of these patients and by the surgeons and healthcare providers who treat them.
Providing exceptional response starts with an understanding of surgeon customers and the challenges they face. Our team actively listens to and interacts with the surgeon community regarding patient pathologies, complex surgical techniques, and tough clinical challenges.
Our team is comprised of an experienced sales force and product development engine who are available to answer questions and provide technical support as needed. Exceptional response is one of the keys to our unprecedented growth.
Lockdown Medical
In the event of an acromioclavicular joint (ACJ) dislocation, LockDown provides an elegant and easy solution: a synthetic braid that loops around the coracoid, passes around the posterior of the clavicle and then is secured with a single screw in the anterior-posterior direction.
Lockdown Medical
In the event of an acromioclavicular joint (ACJ) dislocation, LockDown provides an elegant and easy solution: a synthetic braid that loops around the coracoid, passes around the posterior of the clavicle and then is secured with a single screw in the anterior-posterior direction. This provides stability while allowing natural rotation of the clavicle.
It has been our mission to work with leading surgeons around the World and through their practice introduce LockDown our device to treat the Acromioclavicular joint injury. LockDown ACJ stabilization has a strong clinical heritage spanning more than 13 years and with over 2,000 devices implanted per year, you can be assured that the Lockdown ACJ stabilization system has proven itself time and again to be the number one choice for surgeons in many countries worldwide.
Orthalign
Our team is committed to providing orthopedic surgeons with user-friendly, cost-effective, cutting-edge technology for precise alignment during hip and knee replacement surgery.
Orthalign
Our team is committed to providing orthopedic surgeons with user-friendly, cost-effective, cutting-edge technology for precise alignment during hip and knee replacement surgery
Providing tibial and femoral navigation for total knee arthroplasty in a palm-sized, single-use device compatible with all standard implant systems. Technology that navigates cup placement and measures changes in leg length to improve accuracy, reduce outliers and minimize the need for fluoro.
Stim wave
Stimwave offers two types of neurostimulator devices that provide long-lasting pain relief. The Freedom SCS System and StimQ PNS System relieve pain by sending electrical stimulation to block those pain signals from reaching the brain.
Stim wave
Stimwave offers two types of neurostimulator devices that provide long-lasting pain relief. The Freedom SCS System and StimQ PNS System relieve pain by sending electrical stimulation to block those pain signals from reaching the brain. Unlike any other device, Stimwave is powered wirelessly and without an implanted battery.
Stimwave Freedom Stimulators provide you with true “freedom” from batteries, cables, and implanted generators. The external compact device uses simple buttons to change therapy levels and can be recharged easily via a micro-USB.
Stimwave Provides the Freedom to Return to Life.
Raumedic - catheter & monitoring devices
Raumedic
Raumedic is a subsidiary of Rehau that is a company with extensive experience, over 70 years in the field of development, research and production of medical equipment and carries a wide and varied portfolio of catheters for monitoring intracranial pressure to the parenchyma, ventricles and epidural areas required for the treatment of various types of head injuries. Understanding that in cases of head injuries that require rapid decision-making, accurate and continuous results and metrics must be obtained, the company decided to invest in developing technology that will give the medical staff optimal diagnostic ability and thus help reduce mortality and improve neurological recovery for patients worldwide.
Multi-Modal Neuromonitoring with Measuring Catheters - In neurosurgery the causes of cerebral damages can be diagnosed early on thanks to multi-modal neuromonitoring performed with measuring catheters. If the parameters change, they are safely, quickly and accurately displayed on the patient monitor. As a result, the patient can be treated correctly.
Extensive Product Portfolio - NEUROVENT measuring catheters are used to monitor parenchyma, ventricular and epidural measurements in the brain. The measurement can be performed by connecting the device with a cable or with the help of telemetry. Due to the comprehensive product portfolio of our NEUROVENT catheters, we offer the right catheter for every indication and for a variety of treatment methods. Furthermore, a single catheter combines up to three measuring functions: ICP (intracranial pressure), ICT (intracranial temperature), and ptiO2 (oxygen partial pressure). In addition to the NEUROVENT catheters, our product portfolio for the field of neurosurgery also offers a great number of accessories. These are used to implant the catheters safely, to document and analyse the measured results and to transfer the measured results to all common patient monitors in neurosurgery.
tVNS Technologies
tVNS® is a certified medical device for the treatment of symptoms of sympathovagal imbalance and was specially developed for patients who are not free of symptoms despite drug therapy.
From Access to Closure
tVNS® is a certified medical device for the treatment of symptoms of sympathovagal imbalance and was specially developed for patients who are not free of symptoms despite drug therapy.
Special nerve fibers are activated by gentle electrical impulses (neurostimulation) via an ear electrode on the ear. The user can determine the intensity of the impulses themself.
tVNS® has been used by thousands of patients and is a treatment with very few side effects.